GLMD Galmed Pharmaceuticals Ltd: Enterprise Value-to-Revenue Ratio

Public company logo of Galmed Pharmaceuticals (GLMD)

The EV/Sales history demonstrates how the market values Galmed Pharmaceuticals (GLMD), which implements advanced therapies for metabolic liver disorders. The parameter reaches 0.00, while the company adheres to environmental regulations when working with laboratory reagents. The business's fundamental potential relies on small molecule synthesis and large-scale trials of the drug Aramchol to combat chronic pathologies.

Galmed Pharma (GLMD) EV/Sales Multiple: for the period 11/23/2025 - 09/10/2026

Financial and market metric breakdowns for Galmed Pharmaceuticals Ltd. (GLMD)

- current quotes and average value forecast:
Initial company analysis:Galmed Pharmaceuticals Ltd
Finished products of galmedpharma.com

This metric compares the total enterprise value to annual revenue, excluding the impact of debt load to determine the actual market value of one dollar of sales. By analyzing the EV/Sales multiple history, an investor can discern the efficiency of the mobile capital of Galmed Pharmaceuticals (GLMD), whose clinical research outsourcing strategy minimizes capital expenditures and directly reflects the purity of this valuation.